TSMHT
OPK icon

Thurston Springer Miller Herd & Titak’s Opko Health OPK Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio OPK Stock Details OPK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-37
Closed -$55 – 1375
2024
Q3 		$55 Hold
37
– – ﹤0.01% 1530
2024
Q2 		$46 Buy
+37
New +$48 ﹤0.01% 1512

Other funds holding OPK

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's OPK Position: Q4 2024 in Review

Thurston Springer Miller Herd & Titak sold out of Opko Health (OPK) in Q4 2024, closing a stake of 37 shares — an estimated $55 sold.

Thurston Springer Miller Herd & Titak first reported a position in OPK in Q2 2024 and held it in 2 quarters. The position peaked at $55 in Q3 2024. 235 funds tracked by Wall St. Rank hold OPK as of Q4 2024.

  • Thurston Springer Miller Herd & Titak reported no remaining Opko Health position as of Q4 2024 after selling out during the quarter.
  • Thurston Springer Miller Herd & Titak sold 37 Opko Health shares in Q4 2024, an estimated $55.
  • Thurston Springer Miller Herd & Titak first reported a position in Opko Health in Q2 2024 and held it in 2 quarters.
  • Thurston Springer Miller Herd & Titak's Opko Health position peaked at $55 in Q3 2024.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q4 2024.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q4 2024, filed 14 Jan 2025.